Description
CJC-1295 DAC 5mg — long-acting GHRH analogue for GH research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
CJC-1295 DAC is a synthetic GHRH analogue with a Drug Affinity Complex — a lysine linker attached to a reactive group that binds covalently to serum albumin after injection. This extends its half-life from minutes to approximately 6-8 days.
What the Research Shows
Research has examined CJC-1295 DAC’s effects on sustained GH elevation compared to non-DAC versions. The prolonged half-life produces continuous rather than pulsatile GH release patterns.
Studies investigate its effects on IGF-1 levels, body composition parameters, and GH axis modulation. Published clinical data documents its pharmacokinetics and dose-response relationships.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity. No generic overseas certificates.
→ Full CJC-1295 DAC Research Guide
Purity: ≥99% (HPLC)
Form: Lyophilised powder
Molecular Weight: 3647.28 Da
CAS: 863288-34-0
Half-life: ~6-8 days (albumin-bound)
Research: PubMed
▸ Australian university verified
▸ ≥99% purity guaranteed
▸ Same-day dispatch from Sydney
▸ Research-grade lyophilised powder
Related Research and Resources
For research use only. Not for human consumption.
